Reduction in the hepatocellular carcinoma antioncogene <i>SLC39A14</i> during the malignant progression of hepatocellular carcinoma
<i>SLC39A14</i> dysregulation promotes HCC progression through BCL-2/BAX/Caspase-3 apoptotic axis and epithelial-mesenchymal transition transformation axis, suggesting potential therapeutic targets.
Authors
- Xuehua Wan (ORCID: https://orcid.org/0000-0002-6367-848X)
- Ming-Xuan Wang
- Tong Mu
- Wei Guo (ORCID: https://orcid.org/0000-0003-2471-5767)
- Zhaodi Jiang (ORCID: https://orcid.org/0000-0001-9480-6942)
- Yongxiang Yi (ORCID: https://orcid.org/0000-0002-9465-1212)
- Junwei Li (ORCID: https://orcid.org/0009-0000-0919-2289)
- Kan Xu (ORCID: https://orcid.org/0009-0008-4376-885X)
Institutions
- Nanjing University of Chinese Medicine (CN)
- Nanjing Drum Tower Hospital (CN)
Publication Details
- Journal
- World Journal of Gastrointestinal Surgery
- Published
- 2025-10-23
- DOI
- https://doi.org/10.4240/wjgs.v17.i10.111454
- Primary Topic
- Monoclonal and Polyclonal Antibodies Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00